- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07860164
Improving Officer and Civilian Health
Improving Officer and Civilian Health Improving Officer and Civilian Health Through Macro-level Changes in North Texas: Phase 2: Intervention Pilot Testing
As a profession, law enforcement produces unique occupational health outcomes for officers and civilians. To date, most studies have focused on improving health outcomes related to law enforcement from a microlevel perspective, with particular attention to individual and behavioral factors. Such a focus misses the broader macro-level factors that perpetuate occupational harms. To address this gap, this study uses the PRECEDE-PROCEED model of intervention development to examine modifiable macro-level factors contributing to adverse occupational health outcomes for law enforcement and civilians. Using a mixed-method design and partnering with local law enforcement agencies, the investigators will implement and test an intervention to reduce occupational health harms related to law enforcement.
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
The study examines the acceptability and feasibility of three intervention components aimed at improving officer well-being and civilian outcomes: 1) a novel conversational AI software that interacts with officers during civilian interactions; 2) digitization of cite and release paperwork; and 3) an alternate response unit for calls not needing officer response. The first two intervention components will be implemented and piloted, while the alternative response unit will be evaluated solely for acceptability and feasibility.
This mixed-methods, solutions-oriented prospective cohort study has the following aims: Aim 1a: Determine the acceptability and feasibility of using AI to reinforce officers' de-escalation training, avoid using force, increase cite and release when eligible, and refer civilians to behavioral health, public health, and social service organizations. Aim 1b: Assess the acceptability and feasibility of digitizing required paperwork to reduce arrests for low-level offenses where arrests are not statutorily required. Aim 1c: Determine the acceptability and feasibility of an alternate response unit for behavioral health 911 calls, emphasizing stakeholder inquiry to assess appropriateness and potential impact. Aim 2a: Pilot AI software and evaluate outcomes related to use of force, citations instead of arrests, and referrals to social, behavioral, and public health services, assessing how implementation processes influence effectiveness. Aim 2b: Pilot digitized cite & release paperwork, evaluating arrest and citation outcomes, with a focus on workflow adoption and officer behavior change. Aim 2c: Reduce officers' moral injury by empowering citation over arrest for eligible civilians, examining how the intervention and support processes affect individual well-being (job satisfaction, depression, and anxiety).
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Linda Fulmer, M.Ed.
- Telefonnummer: 817-451-8740
- E-post: lindafulmer@sbcglobal.net
Studera Kontakt Backup
- Namn: Nolan Kline, PhD, MPH, CPH
- Telefonnummer: 407.266.1000
- E-post: nolan.kline@ucf.edu
Studieorter
-
-
Texas
-
Fort Worth, Texas, Förenta staterna, 76103
- Rekrytering
- Healthy Tarrant County Collaboration
-
Kontakt:
- Linda Fulmer, M.Ed.
- Telefonnummer: 817-451-8740
- E-post: lindafulmer@sbcglobal.net
-
Kontakt:
- Tamara Johnson, BS
- Telefonnummer: 214-552-5456
- E-post: tjohnson@ensoapothecary.com
-
Huvudutredare:
- Linda Fulmer, M.Ed.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- All Aims: Individuals who speak English.
- All Aims: Individuals who are at least 18 years or older.
- Aim 1a, Aim 2a, Aim 2b, Aim 2c: Law enforcement officers from the Tarrant County Sheriff's Department who have been in their role for six months or longer.
- Aim 1b: Staff members in the Tarrant County District Attorneys in office who have been in their role for one year or longer.
- Aim 1c: Hospital emergency department staff who have been in their position for at least one year.
- Aim 1c: Elected officials who have been in their position for at least one year.
- Aim 1c: 911 Dispatchers who have been in their position for at least one year.
- Aim 1c: Employees with the Tarrant County mental health authority
Exclusion Criteria:
- All Aims: Individuals who do not speak English.
- All Aims: Individuals under the age of 18.
- Aim 1a, Aim 2a, Aim 2b, Aim 2c: Individuals not currently employed by the Tarrant County Sheriff's Department or have not been employed for at least six months in the department.
- Aim 1b: District Attorneys outside of Tarrant County or have not been in their position for at least 6 months.
- Aim 1c: Elected officials who have not been in their position for one year or work outside of Tarrant County.
- Aim 1c: Hospital emergency department staff who have not been in their position for at least one year.
- Aim 1c: 911 Dispatchers who have been in their position for at least one year.
- Aim 1c: Employees with the Tarrant County mental health authority who have not been in their position for at least one year. -
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Use of AI
Use of an AI assistant by police to reduce use of force and traumatizing experiences. |
Software enabled analysis to identify heightened stress level in police indicating a need for additional support to facilitate their well-being leading to improved job performance. |
|
Aktiv komparator: Digitizing Cite & Release Paperwork
Putting a paper form into digital format to increase ease of use of the citation over arrest process. |
Software enabled analysis to identify heightened stress level in police indicating a need for additional support to facilitate their well-being leading to improved job performance. |
|
Aktiv komparator: Alternative Response Unit
Acceptability and feasibility study to determine local political willingness to pilot test a stand-alone alternate response unit to respond to behavioral health crisis calls. |
Software enabled analysis to identify heightened stress level in police indicating a need for additional support to facilitate their well-being leading to improved job performance. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of Citation Eligible Offenses Resolved Via Citation versus Arrest
Tidsram: Through the study completion, approximately 3 years.
|
Count of citation-eligible misdemeanor offenses resolved through citation/cite-and-release versus arrest, as recorded in agency arrest/CAD data. |
Through the study completion, approximately 3 years.
|
|
Number of Use of Force Incidents
Tidsram: Through the study completion, approximately 3 years.
|
Total number of use-of-force incidents recorded in agency administrative data, reviewed retrospectively (pre-intervention) and prospectively throughout the intervention period. |
Through the study completion, approximately 3 years.
|
|
Generalized Anxiety and Depression Scale
Tidsram: Baseline and follow-up estimated at six months.
|
PHQ9 GAD7 - Generalized Anxiety and Depression Scale; Surveys will be adapted for the audience. |
Baseline and follow-up estimated at six months.
|
|
Moral Injury Events Scale for Law Enforcement (MIES-LE)
Tidsram: Baseline & follow-up estimated six months apart
|
Assesses law enforcement exposure to events that may create moral injury. Survey will be adapted to the audience. |
Baseline & follow-up estimated six months apart
|
|
The Operational Police Stress Questionnaire
Tidsram: Baseline with follow-up estimated at six months.
|
PSQ-OP - The Operational Police Stress Questionnaire. Surveys will be adapted for audience. |
Baseline with follow-up estimated at six months.
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Nolan Kline, PhD, MPH, CPH, University of Central Florida
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- STUDY00008634
- 3OT2OD035659-01S3 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
All IPD collected throughout the trial shared with the research team members. No IPD will be shared in publication or outside the research team.
Tidsram för IPD-delning
For approximately 3 years through the end of the study on September 19, 2028.
Kriterier för IPD Sharing Access
The only identifiable data that will be collected are names, emails, phone numbers, and audio recordings for the purpose of scheduling surveys and interviews and for interviews. Interview recordings will be transcribed as close to verbatim as possible. The investigators will utilize Rev software to transcribe the interviews and then review the interviews for accuracy. All participants will be given pseudonyms. All study data will be stored in the password protected UCF OneDrive for 5 years after study closure, per Florida law. Information (or samples) that are collected as part of this research will not be used or distributed for future research studies, even if all identifiers are removed.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- ANALYTIC_CODE
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .